Mesenchymal Stem Cells Promote Mammosphere Formation and Decrease E-Cadherin in Normal and Malignant Breast Cells
Ann H. Klopp(The University of Texas MD Anderson Cancer Center), Wendy A. Woodward(The University of Texas MD Anderson Cancer Center), Lara Lacerda(The University of Texas MD Anderson Cancer Center), Savitri Krishnamurthy(The University of Texas MD Anderson Cancer Center), Rogério Gaspar(University of Lisbon), Massimo Cristofanilli(Cornell University), Michael T. Lewis(Baylor College of Medicine), James M. Reuben(The University of Texas MD Anderson Cancer Center), Bisrat G. Debeb(The University of Texas MD Anderson Cancer Center), Thomas A. Buchholz(Scripps MD Anderson Cancer Center), Mauro Ferrari(University of Pisa), Michael Andreeff(The University of Texas MD Anderson Cancer Center), Wei Xu(Nanjing Medical University), Frank C. Marini(The University of Texas MD Anderson Cancer Center), Xiaomei Zhang(The University of Texas MD Anderson Cancer Center), Li Li(The University of Texas MD Anderson Cancer Center), Erika L. Spaeth(Bank of America), Anshul Gupta(The University of Texas MD Anderson Cancer Center), Travis Solley(The University of Texas MD Anderson Cancer Center)
Cited by 175
Related Papers
Palbociclib in Hormone-Receptor–Positive Advanced Breast Cancer
|New England Journal of Medicine|2015|1.6k
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
|Proceedings of the National Academy of Sciences|2009|1.4k
Overall Survival with Palbociclib and Fulvestrant in Advanced Breast Cancer
|New England Journal of Medicine|2018|1.3k
Early Results of a Chemoimmunotherapy Regimen of Fludarabine, Cyclophosphamide, and Rituximab As Initial Therapy for Chronic Lymphocytic Leukemia
|Journal of Clinical Oncology|2005|951